Patents by Inventor Robert Lanza

Robert Lanza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050153443
    Abstract: The invention is concerned with producing differentiated cells, tissues and organs from pluripotent and mutlipotent cells. The methods of the invention are particularly useful for producing differentiated cells from pluripotent cells wherein communication between the cells of more than one embryonic germ layer or more than one organ system are required for development along a specific cell lineage. The invention methods are effected by in vivo or in vitro culturing of embryonic and developing or developed allogeneic or xenogeneic cells.
    Type: Application
    Filed: September 23, 2004
    Publication date: July 14, 2005
    Applicant: Advanced Cell Technology, Inc.
    Inventors: Robert Lanza, Michael West
  • Patent number: 6808704
    Abstract: This invention relates to methods for making immune compatible tissues and cells for the purpose of transplantation and tissue engineering, using the techniques of nuclear transfer and cloning. Also encompassed are methods for determining the effect on immune compatibility of expressed transgenes and other genetic manipulations of the engineered cells and tissues.
    Type: Grant
    Filed: September 6, 2000
    Date of Patent: October 26, 2004
    Assignee: Advance Cell Technology, Inc.
    Inventors: Robert Lanza, Michael D. West, Jose Cibelli
  • Publication number: 20040180430
    Abstract: This invention relates to methods for rejuvenating primary cells and for making primary cells of a different type having the same genotype as a primary cell of interest. Also encompassed are methods of re-cloning cloned mammals, particularly methods where the offspring of cloned mammals are designed to be genetically altered in comparison to their cloned parent. Also included are methods for activating endogenous telomerase for the purpose of extending the life span of a primary cell.
    Type: Application
    Filed: March 1, 2004
    Publication date: September 16, 2004
    Inventors: Michael D. West, Jose Cibelli, Robert Lanza
  • Publication number: 20040139489
    Abstract: The present invention concerns the use of chromosomal replacement techniques in the context of producing cloned and transgenic animals, in order to correct chromosome abnormalities or alter autosomal genotypes, and provide for novel breeding pairs by replacing the sex chromosome in animals to be cloned. Replacement of a sex chromosome, or an X or Y chromosome, will result in animals that are autosomally isogenic and sexually non-isogenic (AISN), with “autosomally isogenic” meaning that the paired sets of autosomes (non-sex chromosomes) in each animal are isogenic or identical. Also included in the invention are animals that are both “autosomally” and “allelically” isogenic whereby each particular pair of chromosomes is internally isogenic or identical within a single animal as well as between animals.
    Type: Application
    Filed: August 8, 2003
    Publication date: July 15, 2004
    Inventors: Robert Lanza, Jose Cibelli, Philip Damiani, Michael D West
  • Publication number: 20040031069
    Abstract: Approximately 100 species become extinct a day. Despite increasing interest in using cloning to rescue endangered species, successful interspecies nuclear transfer has not been previously described, and only a few reports of in vitro embryo formation exist. Here it is shown that interspecies nuclear transfer can be used to clone an endangered species with normal karyo- and phenotypic development through implantation and the late stages of fetal growth, resulting in a newborn animal.
    Type: Application
    Filed: August 1, 2003
    Publication date: February 12, 2004
    Inventors: Philip Damiani, Robert Lanza, Jose Cibelli, Michael D. West
  • Publication number: 20030027330
    Abstract: The invention is concerned with producing differentiated cells, tissues and organs from pluripotent and mutlipotent cells. The methods of the invention are particularly useful for producing differentiated cells from pluripotent cells wherein communication between the cells of more than one embryonic germ layer or more than one organ system are required for development along a specific cell lineage. The invention methods are effected by in vivo or in vitro culturing of embryonic and developing or developed allogeneic or xenogeneic cells.
    Type: Application
    Filed: April 2, 2002
    Publication date: February 6, 2003
    Inventors: Robert Lanza, Michael West
  • Publication number: 20020046410
    Abstract: This invention relates to methods for making immune compatible tissues and cells for the purpose of transplantation and tissue engineering, using the techniques of nuclear transfer and cloning. Also encompassed are methods for determining the effect on immune compatibility of expressed transgenes and other genetic manipulations of the engineered cells and tissues.
    Type: Application
    Filed: March 5, 2001
    Publication date: April 18, 2002
    Inventors: Robert Lanza, Michael D. West